Dynavax Technologies Corp
DVAX·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$15.50
Today
+0.0%
YTD
+1.0%
About
Headquartered in Emeryville, California, Dynavax is a healthcare firm that works to leverage the power of the body's adaptive and innate immune responses through receptor stimulation. The company has operated internationally since its foundation in 1996. Assigned the ticker DVAX, the company's stock is available on the NASDAQ CM stock market. Add this stock to your eToro watchlist to keep tabs on the DVAX share price.
Price chart
Closing price history for DVAX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-40.59
P/S (TTM)6.40
P/B (TTM)3.41
Market cap$1.82B
Cap tierSmall-cap
Industry avg P/E-5.31
Profitability
Gross margin83.17%
EBIT margin3.16%
Net margin28.38%
ROE-7.14%
ROA-4.32%
Earnings & Revenue
Revenue (TTM)$330.51M
Revenue growth (1Y)+26.7%
EPS (TTM)-$0.38
Free cash flow$80.54M
Total debt$289.22M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.59
Employees405
Next earnings19 Feb '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.